Myriad Genetics
MYGN
$18.18
Share price
1.11%
Change (1 day)
-14.61%
Change (1 year)
Myriad Genetics (MYGN) - Cash on Hand
Cash on Hand as of December 2023 : $0.14 B
According to Myriad Genetics's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Myriad Genetics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | 22.63% |
| 2022-12-31 | $0.11 B | -66.09% |
| 2021-12-31 | $0.33 B | |
| 2020-06-30 | $0.21 B | 59.09% |
| 2019-06-30 | $0.13 B | -24.2% |
| 2018-06-30 | $0.18 B | 19.84% |
| 2017-06-30 | $0.15 B | -5.22% |
| 2016-06-30 | $0.15 B | 9.81% |
| 2015-06-30 | $0.14 B | -22.32% |
| 2014-06-30 | $0.18 B | -49.94% |
| 2013-06-30 | $0.37 B | 9.33% |
| 2012-06-30 | $0.34 B | -1.71% |
| 2011-06-30 | $0.34 B | -14.08% |
| 2010-06-30 | $0.40 B | 27.26% |
| 2009-06-30 | $0.31 B | -3.61% |
| 2008-06-30 | $0.32 B | 53.53% |
| 2007-06-30 | $0.21 B | -5.99% |
| 2006-06-30 | $0.22 B | 100.05% |
| 2005-06-30 | $0.11 B | -1.32% |
| 2004-06-30 | $0.11 B | 58.52% |
| 2003-06-30 | $72.77 M | -0.41% |
| 2002-06-30 | $73.07 M | -42.56% |
| 2001-06-30 | $0.12 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $7.27 B | 5,066.08% | 🇺🇸 USA |
 Exact Sciences EXAS | $0.77 B | 451.91% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.07 B | 662.11% | 🇺🇸 USA |
 Biocept
BIOC | $6.63 M | -95.29% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $1.60 B | 1,040.62% | 🇺🇸 USA |